Back to rankings

Linde plc (LIN)

NEUTRAL
Basic MaterialsSpecialty ChemicalsUnited Kingdom

Fundamental

66

Price

$486.36

Market Cap

$225.89B

Part 1 · What the company is worth

Overview

Linde produces and delivers industrial gases — oxygen, nitrogen, hydrogen, argon and carbon dioxide, among others — that manufacturers, hospitals, refineries and electronics makers need to run their processes but rarely make themselves. It supplies large customers through dedicated on-site plants built next to their facilities, smaller customers by tanker truck or cylinder, and also has an Engineering unit that designs and builds gas-production plants for third parties, including rival gas companies.

How it makes money

Most revenue comes from long-term, often 15-to-20-year, on-site contracts with take-or-pay minimums that pay Linde whether or not the customer uses the full volume, plus merchant sales of liquefied gas delivered by truck and cylinder gas sold to smaller accounts. Energy and raw-material costs are largely passed through to customers contractually. The Engineering segment instead books lumpy, project-based revenue as it designs and constructs plants, unrelated to the recurring gas-supply business.

Revenue by segment

Americas44.7%

Gas production and distribution across North and South America, Linde's largest geographic segment.

EMEA25.2%

Gas production and distribution across Europe, the Middle East and Africa.

APAC19.6%

Gas production and distribution across Asia Pacific, including electronics and metals customers.

Engineering6.6%

Designs and builds gas-production plants for third-party customers, including other industrial-gas companies.

Other3.9%

Corporate and other smaller activities not allocated to a geographic or engineering segment.

Competitive moat

Switching costs · Wide

Linde's on-site plants are built inside a customer's own facility and connected by pipeline, so switching supplier means relocating an entire gas plant — practically never done once a contract is signed. Combined with a dense, hard-to-replicate network of pipelines and distribution routes built up over decades, this gives Linde a durable, structural advantage over smaller or newer competitors.

What drives demand

Moderately cyclical

Demand is a mix: healthcare and food-grade gases are fairly stable through economic cycles, while sales to chemicals, metals and mining, and energy customers rise and fall with those industries' own investment cycles. Long-term take-or-pay contracts smooth some of this volatility, but the Engineering segment's project backlog can still slow if large customers delay capital projects.

Key risks

  • Energy is the largest cost input — Electricity, natural gas and diesel for distribution are Linde's single largest cost item; while contracts pass through much of this cost, unmitigated spikes or supply disruptions can still hurt margins.
  • Cyclical industrial end markets — Customers in chemicals and energy, and metals and mining are cyclical businesses, and a downturn in these industries reduces the volumes Linde sells and can delay new on-site project starts.
  • Large project backlog execution risk — Linde is building a multibillion-dollar backlog of large on-site and engineering projects; delays, cost overruns, or a customer's own project being cancelled or downsized would slow the growth these projects are meant to deliver.
  • Global operating and regulatory exposure — Operating plants and distribution networks across dozens of countries exposes Linde to currency movements, local regulation and geopolitical disruption in any single market where it has significant invested capital.

The case for

Buyers argue that pipeline-connected, take-or-pay contracts make Linde's core revenue unusually predictable for an industrial company, that a multibillion-dollar project backlog gives visibility into several years of growth, and that scale and route density make Linde structurally hard for smaller gas suppliers to dislodge from existing customer sites.

The case against

Sellers fear that a meaningful share of volumes still depends on cyclical chemicals, metals and energy customers who can cut back sharply in a downturn, that energy-cost pass-through contracts do not fully protect margins in extreme price spikes, and that the large project backlog carries execution and customer-cancellation risk over a multi-year build-out.

Written by the editors, published on August 18, 2026

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance Sheet & Liquidity

Revenue

$35.45B

Trailing 12 months (through 6/30/2026)

Net Income

$7.24B

Trailing 12 months (through 6/30/2026)

Free Cash Flow

$5.09B

Total Equity

$38.24B

Total Liabilities

$47.08B

Current Ratio

0.88

Interest Coverage

37.36

Debt/EBITDA

2.59

Earnings Per Share

Revenue & Net Income

Free Cash Flow

Income Breakdown

Historical statement

Margins over time

Debt over time

How heavy the debt is

Growth grid

Growth — Revenue

Fair Value Estimation

Undervalued

Fair Value

$658.45

Current Price

$486.36

Margin of Safety

+26.1%

Fair Value Range

$476.00 - $840.89

Estimation Methods

Analyst Target:$547.24
DCF:$883.12
PE-based:$417.38
Graham Growth:$797.94
EPV:$189.37
Analyst Consensus:Buy (22B / 6H / 2S)
Last Earnings Surprise:-0.64%

Valuation Metrics

P/E Ratio

31.61

ROE

18.0%

P/B Ratio

5.78

P/FCF

45.41

Gross Margin

-

ROIC

10.3%

Profitability Radar

Value Creation (Economic Moat)

ROIC

10.3%

WACC

7.4%

ROIC − WACC

+2.9 pp

ROIC exceeds the cost of capital — the company is creating value for shareholders.

Fundamental Analysis Criteria

Passed (17)

  • EPS shows upward trend
  • EPS CAGR 12.14%
  • Price CAGR 15.32%
  • ROIC 10.3%
  • Debt/Equity ratio
  • Operating Margin 26.5%
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 18.8%
  • Analyst Consensus 73% Buy
  • PEG Ratio 1.20
  • Earnings Quality (OCF/NI) 1.45
  • Share Dilution -2.0%
  • Net Margin Trend 20.4% vs 20.2%

Failed (9)

  • P/FCF 45.41
  • P/B Ratio 5.78
  • CapEx intensity
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Revenue Growth 5Y 4.5%
  • Earnings Surprise avg -0.2%
  • Piotroski F-Score 4/9

Unavailable (2)

  • Gross Margin NaN%
  • Dividend Payout NaN%

Piotroski F-Score

4/9

Mixed signals: some areas need attention

score
criteria

Earnings Quality

1.45

High quality: earnings backed by cash

Share Dilution

-2.0%

Buying back shares. Shareholder friendly

Governance

Executive Team

NameTitleAge
Mr. Sanjiv LambaCEO & Chairman of the Board61
Mr. Matthew J. White C.F.A.Executive VP & CFO53
Mr. Sean F. DurbinCOO & EVP54
Mr. Guillermo BicharaExecutive VP & Chief Legal Officer50
Mr. Benjamin W. GlazerSenior VP of Americas51
Denny BrownChief Accounting Officer-
Mr. Juan PelaezVice President of Investor Relations-
Karin GriggelChief Compliance Officer-
Ms. Desiree Co BacherSenior VP & Chief Human Resources Officer54
Mr. Moloy BanerjeePresident of ASEAN & South Asia59

Audit Risk

10

Board Risk

8

Compensation Risk

1

Shareholder Rights Risk

4

Part 2 · The price and when to enter

This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.

Latest News

Recent headlines for LIN, sourced from Markets Gazette.

  • 4/1/2026POSITIVE
    Here's How Much You Would Have Made Owning Linde Stock In The Last 10 Years

    Linde plc has demonstrated significant long-term value for its shareholders, with returns over the past decade indicating a robust performance. While specific figures are not detailed in the provided snippet, the title suggests substantial gains for investors who held Linde stock over the last 10 years. This historical performance underscores the company's stability and growth potential within the industrial gases sector. Investors looking for established companies with a track record of delivering shareholder value may find Linde an attractive option, especially given its essential role in various industrial processes.

  • 3/6/2026NEGATIVE
    Medtronic Diabetes Unit MiniMed Falls 2% After $560 Million IPO

    MiniMed Group Inc., a newly separated diabetes management unit from Medtronic Plc, experienced a 2% decline in its stock price during its trading debut. The company successfully raised $560 million through its initial public offering. The initial dip suggests a lukewarm market reception or profit-taking by early investors, despite the significant capital raised. For investors, this initial performance indicates potential short-term volatility and highlights the importance of monitoring post-IPO performance closely.

via Markets Gazette